Managing Myelofibrosis and Anemia

This chapter explores treatment strategies for myelofibrosis-associated anemia, focusing on the role of JAK inhibitors and the factors influencing individual patient decisions. It discusses options for managing anemia, including dosage adjustments and supportive therapies, while emphasizing personalized approaches based on patient responses. Additionally, the chapter highlights the future of therapeutic advancements and the necessity of tailored treatment plans to optimize outcomes.